Preparation and preliminary biological evaluation of [18F]NCQ-115: a new selective reversible dopamine D2 receptor ligand

1993 ◽  
Vol 20 (4) ◽  
pp. 549-555 ◽  
Author(s):  
A. Najafi ◽  
A. Peterson ◽  
M. Buchsbaum ◽  
S. O'Dell ◽  
F. Weihmuller
2008 ◽  
Vol 35 (4) ◽  
pp. 467-473 ◽  
Author(s):  
Philipp T. Meyer ◽  
Dagmar Salber ◽  
Johannes Schiefer ◽  
Markus Cremer ◽  
Wolfgang M. Schaefer ◽  
...  

2011 ◽  
Vol 97 (3) ◽  
pp. 428-435 ◽  
Author(s):  
Denis Boulay ◽  
Ronan Depoortere ◽  
Caroline Louis ◽  
Martine Lacave ◽  
Marie Thérèse Lucas ◽  
...  

Author(s):  
Mathias Schreckenberger ◽  
Stefan H�gele ◽  
Thomas Siessmeier ◽  
Hans-Georg Buchholz ◽  
Heike Armbrust-Henrich ◽  
...  

2001 ◽  
Vol 412 (3) ◽  
pp. 247-254 ◽  
Author(s):  
Abdallah Hadj Tahar ◽  
Anna Ekesbo ◽  
Laurent Grégoire ◽  
Evelyne Bangassoro ◽  
Kjell A Svensson ◽  
...  

2016 ◽  
Vol 81 (4) ◽  
pp. 347-356 ◽  
Author(s):  
Jelena Penjisevic ◽  
Vladimir Sukalovic ◽  
Deana Andric ◽  
Goran Roglic ◽  
Irena Novakovic ◽  
...  

A series of sixteen novel substituted piperidines and (2-methoxyphenyl)piperazines were synthesized, starting from the key intermediates 1-(2-methoxyphenyl)-4-(piperidin-4-yl)piperazine and 1-(2-methoxyphenyl)-4-(piperidin-4-ylmethyl)piperazine. Biological evaluation of the synthesized compounds was pointed out for seven compounds, of which 1-(2-methoxyphenyl)-4-{[1-(2-nitrobenzyl)piperidin-4-yl]methyl}piperazine had the highest affinity for the dopamine D2 receptor. For all seven selected compounds docking analysis was performed in order to establish their structure-to-activity relationship.


Sign in / Sign up

Export Citation Format

Share Document